Validation of Clinical COPD Phenotypes for Prognosis of Long-Term Mortality in Swedish and Dutch Cohorts

References

• Soriano JB, Abajobir AA, Abate KH, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Resp Med. 2017;5(9):691–706. DOI:10.1016/S2213-2600(17)30293-X
   PubMed Web of Science ®Google Scholar
• Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: systematic review and Meta-analysis. Eur Respir J. 2006; Sep28(3):523–532. DOI:10.1183/09031936.06.00124605
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the diagnosis, management, and prevention of chronic ­obstructive lung 406 disease 2017 report: GOLD executive summary. Eur Respir J. (3)2017; 49:1700214.
   PubMed Web of Science ®Google Scholar
• R-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005; Nov60(11):925–931. DOI:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Odeyemi YE, Lewis O, Ngwa J, et al. Does low fev1 in addition to fixed ratio and/or lower limit of normal of FEV1/FVC improve prediction of mortality in COPD? The NHANES-III-linked-mortality cohort. J Natl Med Assoc. 2019;111(1):94–100. DOI:10.1016/j.jnma.2018.06.006
   PubMed Web of Science ®Google Scholar
• Dornhorst AC. Respiratory insufficiency. Lancet. 1955;268(6876):1185–1187.
   PubMedGoogle Scholar
• Wardlaw AJ, Silverman M, Siva R, et al. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy. 2005;35(10):1254–1262. DOI:10.1111/j.1365-2222.2005.02344.x
   PubMed Web of Science ®Google Scholar
• Burgel PR, Roche N, Paillasseur JL, et al. Clinical COPD phenotypes identified by cluster analysis: validation with mortality. Eur Respir J. INITIATIVES BPCO Scientific Committee 2012; Aug40(2):495–496. DOI:10.1183/09031936.00228511
   PubMed Web of Science ®Google Scholar
• Burgel PR, Paillasseur JL, Peene B, et al. Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PLoS One. 2012;7(12):e51048. DOI:10.1371/journal.pone.0051048
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Gomez FP, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. 2011;66(5):430–437. DOI:10.1136/thx.2010.154484
   PubMed Web of Science ®Google Scholar
• Burgel PR, Paillasseur JL, Caillaud D, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J. 2010;36(3):531–539. DOI:10.1183/09031936.00175109
   PubMed Web of Science ®Google Scholar
• Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. DOI:10.1164/rccm.201209-1665OC
   PubMed Web of Science ®Google Scholar
• Disantostefano RL, Li H, Rubin DB, et al. Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis. BMJ Open. 2013;3(4):e001838. DOI:10.1136/bmjopen-2012-001838
   PubMed Web of Science ®Google Scholar
• Cho MH, Washko GR, Hoffmann TJ, et al. Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res. 2010;11:30. DOI:10.1186/1465-9921-11-30
   PubMed Web of Science ®Google Scholar
• Pinto LM, Alghamdi M, Benedetti A, et al. Derivation and validation of clinical phenotypes for COPD: a systematic review. Respir Res. 2015;16:50. DOI:10.1186/s12931-015-0208-4
   PubMed Web of Science ®Google Scholar
• Burgel PR, Paillasseur JL, Janssens W, et al. A simple algorithm for the identification of clinical COPD phenotypes. Eur Respir J. 2017;50(5):1701034. DOI:10.1183/13993003.01034-2017
   PubMed Web of Science ®Google Scholar
• Breiman L. Classification and regression trees. Belmont, CA: Wadsworth International Group; 1984. (The Wadsworth statistics/probability series).
   Google Scholar
• Ikram MA, Brusselle G, Ghanbari M, et al. Objectives, design and main findings until 2020 from the rotterdam study. Eur J Epidemiol. 2020;35(5):483–517. DOI:10.1007/s10654-020-00640-5
   PubMed Web of Science ®Google Scholar
• Sundh J, Aberg J, Hasselgren M, et al. Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014. Eur Clin Respir J. 2017;4(1):1409060. DOI:10.1080/20018525.2017.1409060
   PubMed Web of Science ®Google Scholar
• Bestall JC, Paul EA, Garrod R, et al. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; Jul54(7):581–586. DOI:10.1136/thx.54.7.581
   PubMed Web of Science ®Google Scholar
• Giezeman M, Hasselgren M, Lisspers K, et al. Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study. Int J Chron Obstruct Pulmon Dis. 2018;13:3857–3865. DOI:10.2147/COPD.S175641
   PubMed Web of Science ®Google Scholar
• Leening MJ, Kavousi M, Heeringa J, et al. Methods of data collection and definitions of cardiac outcomes in the rotterdam study. Eur J Epidemiol. 2012;27(3):173–185. DOI:10.1007/s10654-012-9668-8
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. DOI:10.1183/09031936.00080312
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry [practice guideline]. Eur Respir J. 2005;26(2):319–338. DOI:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Terzikhan N, Verhamme KM, Hofman A, et al. Prevalence and incidence of COPD in smokers and non-smokers: the rotterdam study. Eur J Epidemiol. 2016;31(8):785–792. DOI:10.1007/s10654-016-0132-z
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187. DOI:10.1164/ajrccm.159.1.9712108
   PubMed Web of Science ®Google Scholar
• Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Eur Respir J Suppl. 1993;16:5–40.
   PubMedGoogle Scholar
• Arne M, Lisspers K, Stallberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010; 104(4):550–556. DOI:10.1016/j.rmed.2009.10.023
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. DOI:10.1056/NEJMoa021322
   PubMed Web of Science ®Google Scholar
• Sundh J, Janson C, Lisspers K, et al. The dyspnoea, obstruction, smoking, exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J. 2012;21(3):295–301. DOI:10.4104/pcrj.2012.00054
   PubMedGoogle Scholar
• Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374(9691):704–711. DOI:10.1016/S0140-6736(09)61301-5
   PubMed Web of Science ®Google Scholar
• Guerra B, Haile SR, Lamprecht B, et al. Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease. BMC Med. 2018;16(1):33. DOI:10.1186/s12916-018-1013-y
   PubMedGoogle Scholar
• Kim J, Lee CH, Hwang SS, et al. The ability of different scoring systems to predict mortality in chronic obstructive pulmonary disease patients: a prospective cohort study. Respiration. 2019;98(6):495–502. DOI:10.1159/000502826
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. DOI:10.1164/rccm.201201-0034OC
   PubMed Web of Science ®Google Scholar
• Ellingsen J, Johansson G, Larsson K, et al. Impact of comorbidities and commonly used drugs on mortality in COPD - Real-World data from a primary care setting. Int J Chron Obstruct Pulmon Dis. 2020;15:235–245. DOI:10.2147/COPD.S231296
   PubMed Web of Science ®Google Scholar
• Bloom CI, Ricciardi F, Smeeth L, et al. Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care. BMC Med. 2019;17(1):73. DOI:10.1186/s12916-019-1310-0
   PubMedGoogle Scholar
• Morales DR, Flynn R, Zhang J, et al. External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches. Respir Med. 2018;138:150–155. DOI:10.1016/j.rmed.2018.04.003
   PubMed Web of Science ®Google Scholar
• Bellou V, Belbasis L, Konstantinidis AK, et al. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:l5358. DOI:10.1136/bmj.l5358
   PubMed Web of Science ®Google Scholar
• Sawalha S, Hedman L, Backman H, et al. The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study. Ther Adv Respir Dis. 2019;13:175346661986005. DOI:10.1177/1753466619860058
   Web of Science ®Google Scholar
• Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284–289. DOI:10.1136/thx.2005.051029
   PubMed Web of Science ®Google Scholar
• Jones RC, Donaldson GC, Chavannes NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE index. Am J Respir Crit Care Med. 2009;180(12):1189–1195. DOI:10.1164/rccm.200902-0271OC
   PubMed Web of Science ®Google Scholar
• Calverley PM, Anzueto AR, Dusser D, et al. Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD. COPD. 2018;13:1297–1308. DOI:10.2147/COPD.S153631
   Google Scholar
• Marin JM, Alfageme I, Almagro P, et al. Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur Respir J. 2013;42(2):323–332. DOI:10.1183/09031936.00121012
   PubMed Web of Science ®Google Scholar